Back to Search
Start Over
Phase II study of intraperitoneal paclitaxel plus S-1/oxaliplatin for gastric cancer with peritoneal metastasis: SOX+IP PTX trial
- Source :
- Journal of Clinical Oncology. 34:4040-4040
- Publication Year :
- 2016
- Publisher :
- American Society of Clinical Oncology (ASCO), 2016.
-
Abstract
- 4040Background: Intraperitoneal (IP) chemotherapy is a promising treatment option for gastric cancer with peritoneal metastasis. We previously reported the safety and efficacy of IP paclitaxel (PTX...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Peritoneal metastasis
Chemotherapy
business.industry
medicine.medical_treatment
Phases of clinical research
Cancer
Treatment options
medicine.disease
Oxaliplatin
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Paclitaxel
chemistry
030220 oncology & carcinogenesis
Internal medicine
medicine
030211 gastroenterology & hepatology
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 34
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........45e198a341c97941cd3cbcf750959853